Sleep News and Research

Latest Sleep News and Research

Study: Rates of HIV have increased in Pakistan's general population

Rates of HIV have increased in Pakistan's general population, as the virus has spread beyond at-risk groups to women and their children, according to an international team of researchers, including a University of Florida scientist.

25 Aug 2011

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Cortex Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent that protects the use of AMPAKINE molecules for the treatment or prevention of respiratory depression.

25 Aug 2011

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

25 Aug 2011

Commuting worst for women with pre-schoolers

Commuting to and from work affects women worse than men and mothers of pre-school youngsters are the worst affected, says a new study. They are four times more likely to suffer mental problems than men with children of a similar age.

23 Aug 2011

HealthAmerica expands social media platform through relationship with CaféWell

HealthAmerica announced today the expansion of its social networking community devoted solely to the health and well-being of its members through a relationship with CaféWell.

23 Aug 2011

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

23 Aug 2011

Narcolepsy more prevalent in China during April

New research shows that the occurrence of narcolepsy in China is highly correlated to a seasonal pattern, with onset most frequent in April.

22 Aug 2011

Winter airway infections appear to trigger narcolepsy: Study

The onset of narcolepsy appears to follow seasonal patterns of H1N1 and other upper airway infections, according to a new study of patients in China that was led by Stanford University School of Medicine narcolepsy expert Emmanuel Mignot, MD.

22 Aug 2011

Study examines how gay and lesbian couples promote each other's unhealthy habits

For better or for worse, in sickness and in health - there's a long line of research that associates marriage with reducing unhealthy habits such as smoking, and promoting better health habits such as regular checkups.

20 Aug 2011

St. Joseph's Women's Hospital inaugurates new 64-suite neonatal intensive care unit

Most expectant mothers enjoy optimistic dreams of delivering a healthy baby and soon leaving the hospital with their new bundle of joy.

20 Aug 2011

ASA launches new video that highlights need for responsible use of pain medication

The American Society of Anesthesiologists launched a new video today on its lifelinepatients YouTube channel that highlights the need for responsible use of pain medication and proper disposal of the drugs.

19 Aug 2011

Seven UC scientists receive 2011 NARSAD Grants for brain and behavior research

The Brain & Behavior Research Foundation has awarded $1.5 million in NARSAD Distinguished Investigator Grants to fund highly esteemed scientists for research on brain and behavior disorders.

19 Aug 2011

Cortex second quarter net loss decreases to $356,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company's option agreement with Servier, France's largest privately held pharmaceutical company.

18 Aug 2011

National analysis identifies Columbus as one of the Hypertension Hot Spots in the U.S.

A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications.

18 Aug 2011

Alcohol before bed hampers sleep: Study

A new small-scale study showed the impact of drinking before going to bed on heart rate and sleep.

18 Aug 2011

Scientists demonstrate how Modified Citrus Pectin enhances immune function

Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function.

16 Aug 2011

Geisinger researchers develop new PTSD prediction tool

A new post-traumatic stress disorder (PTSD) prediction tool, developed by Geisinger Health System researchers, is simple to administer and appears to outperform other screening methods, according to new findings published electronically in the August issue of the journal General Hospital Psychiatry.

16 Aug 2011

Second annual CNS Summit to shape the future of drug development

Segal Institute for Clinical Research, a consortium of CNS and women's health research sites, is preparing to again be actively involved in CNS Summit this coming fall.

12 Aug 2011

Researchers describe novel skin-mounted electronics in Science journal

Engineers have developed a device platform that combines electronic components for sensing, medical diagnostics, communications and human-machine interfaces, all on an ultrathin skin-like patch that mounts directly onto the skin with the ease, flexibility and comfort of a temporary tattoo.

12 Aug 2011

CPAP withdrawal leads to return of obstructive sleep apnea

The benefits of continuous positive airway pressure machines (CPAP) for patients with obstructive sleep apnea (OSA) are quickly reversed when the therapy is withdrawn, according to Swiss research.

12 Aug 2011